New Delhi, March 20 -- Narayana Health is ramping up its oncology offerings with a new chain of cancer care centres, taking the treatment to patients and keeping them out of hospitals as the disease b... Read More
New Delhi, March 16 -- Repercussions of US President Donald Trump's tariffs on China will likely be felt not just in several domestic sectors but also in key export destinations for Indian companies a... Read More
New Delhi, March 13 -- A blockbuster diabetes drug will soon be available to Indian patients at a tenth of its cost, as its patent expires. At least four Indian generics players have launched cheaper ... Read More
New Delhi, March 11 -- Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker s... Read More
New Delhi, March 10 -- India's drugmakers saw healthy revenue growth across all therapies in February as they debuted new drugs and raised prices, an industry report showed. Sales in the domestic pha... Read More
New Delhi, March 6 -- Danish drugmaker Novo Nordisk is prepared to enter the Indian market and other markets with its blockbuster drug Ozempic, despite losing patent exclusivity early next year. "Eve... Read More
New Delhi, March 6 -- AstraZeneca India has seen its profit and revenue jump in the past year, driven by a robust product portfolio focused on cancer and non-communicable diseases. The drugmaker's Bri... Read More
New Delhi, March 5 -- India's digital health market has seen a sharp rise in the past decade, and is expected to grow tenfold in the next decade. Now in its second leg of growth with the integration o... Read More
New Delhi, March 3 -- India's second-largest pathology lab chain, Metropolis Healthcare, is strengthening its foothold in North India with another acquisition. The diagnostics player announced Monday ... Read More
Mumbai, Feb. 27 -- The Central Drugs Standard Control Organisation (CDSCO) is in the process of creating guidelines to regulate cell and gene therapies and upgrading the framework to regulate biosimil... Read More